NCT06575725 2024-11-21Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal CancerCity of Hope Medical CenterPhase 2 Withdrawn